Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Sperovid Nasal Spray in Acute Rhinosinusitis
NCT05999955Phase 2Completed
- Sponsor
- Huro Biotech
- Start
- Dec 2022
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
A Phase 2 trial of Bacillus subtilis DSM32444 in acute rhinosinusitis (ARS), sponsored by Huro Biotech. Started Dec 2022; status: completed.
02
Drugs
Bacillus subtilis DSM32444
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on NCT05999955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05999955.